FY2026(2nd quarter) Consolidated Financial Results for the Six Months Ended September 30, 2026(Based on Japanese GAAP) (194K/15P)

TOWA Pharmaceutical Co. Ltd. published this content on November 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 11, 2026 at 06:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]